Cancer

The FDA announced it has authorized the marketing of 20 Zyn nicotine pouch products, citing their greater health benefits vs. cigarettes and other tobacco products.

A novel topical gel, HT-001, has shown potential as a treatment for cutaneous side effects from epidermal growth factor receptor inhibitor cancer therapy, according to a Hoth Therapeutics press release detailing phase 2a interim data.

One in eight women will suffer from breast cancer in their lifetime. Eight percent will decline treatment due to the fear of alopecia.

In a nonoccupational setting, low ambient benzene exposure over a year was linked to a heightened mortality risk, according to results published in American Journal of Respiratory and Critical Care Medicine.

As the year comes to a close, Healio Dermatology has assembled this year’s most-read cutaneous oncology articles.

WASHINGTON — In this video, Namrata Singh, MD, MSCI, highlights two posters from her team investigating associations between cancer and rheumatoid arthritis, led by “rising stars.”

Children with cancer more often died at home less often than adults, according to study results.

Veterans continue to experience worse health outcomes than the general population.

A mind-body intervention program had positive effects on quality of life for people with cancer, according to a pilot study.